Regulatory News
Tuesday, April 12, 2016
BRIEF-Valeant Pharmaceuticals receives notice of default from bondholders due to delayed 10-K Filing
April 12 (Reuters) - Valeant Pharmaceuticals International
Inc :
Read more
No comments:
Post a Comment
Newer Post
Older Post
Home
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment